2021 CPIP-I Case 9: Hematology – Diagnostic Approach to Blastic-Appearing Hematolymphoid Neoplasms - CPIP0909W.2021
Untitled Document


Review the differential diagnosis of blastic proliferations and ensure proficiency in the timely workup and identification of these life-threatening diseases by understanding potential diagnostic pitfalls.

Credit Type: CME
Duration: 1 hour 15 minutes
Launch Date: September 20, 2021
Expiration Date: September 19, 2024 12:00 AM (ET)
Pricing: Junior Member Fee: $10.00
MOC Category: Medical Knowledge, Patient Care

Registration Information
THIS ACTIVITY REQUIRES CREDIT CARD PAYMENT. If you ordered this product in advance, click Learning Search to locate the activity.

To enroll in the series with one easy payment, or to enroll multiple participants from the same institution, call 800-323-4040 option 1. This option is only available until December 31, 2021, after this date this activity is only accessible by an online credit card payment.

Description
Acute myeloid leukemia and blastic-appearing hematolymphoid neoplasms may present in a variety of ways. These critical diagnoses require timely identification to enable prompt initiation of appropriate therapy. The pathologist plays a crucial role in ensuring the use of appropriate diagnostic, predictive, and prognostic ancillary studies to enable cost-effective, high quality care.

This clinical pathology activity is intended for pathologists.

Objectives
After completing this activity, you should be able to:

  1. Discriminate acute myeloid leukemia (AML) from other blastic-appearing hematolymphoid neoplasms.
  2. Describe the characteristic clinical, morphologic, immunophenotypic, and genetic features of several important subtypes of AML.
  3. Describe the recommended evidence-based predictive and prognostic tests once a diagnosis of AML has been established.

Related Link
Clinical Pathology Improvement Program

CME Information
Accreditation: The College of American Pathologists (CAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Category 1: The College of American Pathologists designates this internet enduring material educational activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Completion Requirements
You must answer the assessment questions and complete the evaluation to claim credit and print your certificate.

Payment Information
To pay with a check, print a copy of this page and send it with your check to the address below. You will be notified when your payment has been processed and you have been registered into the activity.

College of American Pathologists
CAP Learning
325 Waukegan Road
Northfield, IL 60093-2750

Refund Policy
Refunds will be handled on an exception basis. Please submit your request to the CAP in writing via email at education@cap.org or fax at 847-832-8006.

Technical Requirements
Pop-up blockers must be turned off.

CAP Learning has recognized that some Veteran’s Administration, US Government, and military participants may have difficulty accessing the online assessment portion of this activity. If you experience difficulty or have any questions, please contact a representative of the CAP Learning Division at 800-323-4040 option 1 or education@cap.org.

Availability
This activity and evaluation are available September 20, 2021, and expire September 19, 2024, at 12:00 AM (ET). You must claim credit by this date and time.

CC: CPIP0909W.2021






Non-Member Price:   $59.00  
 
Member Price:  $45.00   


2021 CPIP-I Case 9: Hematology – Diagnostic Approach to Blastic-Appearing Hematolymphoid Neoplasms